"Drug-Eluting Stents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Stents that are covered with materials that are embedded with chemicals that are gradually released into the surrounding milieu.
Concept/Terms
Drug-Eluting Stents- Drug-Eluting Stents
- Drug Eluting Stents
- Drug-Eluting Stent
- Stent, Drug-Eluting
- Stents, Drug-Eluting
- Stents, Drug Eluting
Drug-Coated Stents- Drug-Coated Stents
- Drug Coated Stents
- Drug-Coated Stent
- Stent, Drug-Coated
- Stents, Drug-Coated
- Stents, Drug Coated
Below are MeSH descriptors whose meaning is more general than "Drug-Eluting Stents".
Below are MeSH descriptors whose meaning is more specific than "Drug-Eluting Stents".
This graph shows the total number of publications written about "Drug-Eluting Stents" by people in Harvard Catalyst Profiles by year, and whether "Drug-Eluting Stents" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 0 | 1 | 1 |
| 2007 | 14 | 1 | 15 |
| 2008 | 42 | 8 | 50 |
| 2009 | 41 | 7 | 48 |
| 2010 | 28 | 9 | 37 |
| 2011 | 39 | 5 | 44 |
| 2012 | 35 | 6 | 41 |
| 2013 | 21 | 6 | 27 |
| 2014 | 23 | 8 | 31 |
| 2015 | 34 | 8 | 42 |
| 2016 | 31 | 17 | 48 |
| 2017 | 26 | 10 | 36 |
| 2018 | 17 | 8 | 25 |
| 2019 | 25 | 12 | 37 |
| 2020 | 33 | 7 | 40 |
| 2021 | 25 | 4 | 29 |
| 2022 | 13 | 0 | 13 |
| 2023 | 2 | 0 | 2 |
Below are the most recent publications written about "Drug-Eluting Stents" by people in Profiles.
-
Outcomes of Medical Therapy Plus PCI for Multivessel or Left Main CAD Ineligible for Surgery. JACC Cardiovasc Interv. 2023 Feb 13; 16(3):261-273.
-
Long-Term Outcomes and Duration of Dual Antiplatelet Therapy After Coronary Intervention With Second-Generation Drug-Eluting Stents: The Veterans Affairs Extended DAPT Study. J Am Heart Assoc. 2023 01 17; 12(2):e027055.
-
From IMPERIALism to EMINENence: The Noble Rise of the Second-Generation Peripheral Drug-Eluting Stent. Circulation. 2022 11 22; 146(21):1577-1580.
-
Utilization of Non-Drug-Eluting Devices for Inpatient Percutaneous Coronary Intervention in the United States. Am J Cardiol. 2023 01 01; 186:209-215.
-
Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents: BIOFLOW V Final 5-Year Outcomes. JACC Cardiovasc Interv. 2022 09 26; 15(18):1852-1860.
-
Percutaneous coronary intervention versus coronary artery bypass graft surgery in dialysis-dependent patients: A pooled meta-analysis of reconstructed time-to-event data. J Card Surg. 2022 Oct; 37(10):3365-3373.
-
Concomitant Drug-Coated Balloon Angioplasty With Bail-Out Use of Eluvia Drug-Eluting Stent: Is There Any Downside to a Double Dose of Paclitaxel? J Invasive Cardiol. 2022 06; 34(6):E469-E476.
-
Acute Coronary Syndrome and Aortic Stenosis: A Lethal Combo! Can J Cardiol. 2022 08; 38(8):1130-1131.
-
A Senolytic-Eluting Coronary Stent for the Prevention of In-Stent Restenosis. ACS Biomater Sci Eng. 2022 05 09; 8(5):1921-1929.
-
The effect of diabetes on surgical versus percutaneous left main revascularization outcomes: a systematic review and meta-analysis. J Cardiothorac Surg. 2022 Apr 01; 17(1):61.